Pallavi K. Lele
FDA investigator
Appears on 1 document from 2018, mostly at sites in Tennessee. Most often cites design and construction features (21 CFR 211.42(a)).
- 1
- Documents on file
- 13.0
- Observations per 483
- 2018
- First seen
- 2018
- Most recent
What they cite most
From 13 observations- 21 CFR 211.42(a)Design and construction features4
- 21 CFR 211.192Production record review2
- 21 CFR 211.100(b)Written procedures; deviations1
- 21 CFR 211.110(a)(3)Sampling and testing of in-process materials and drug products1
- 21 CFR 211.113(b)Control of microbiological contamination1
- 21 CFR 211.160(b)(4)General requirements1
Activity by year
2018: 1
Where
Tennessee 1
Often inspects with
Is Pallavi K. Lele coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2018-04-27 | 483 Wells Pharmacy Network, LLCApr 27, 2018 · Dyersburg, Tennessee | Dyersburg, Tennessee | 13 |
About this profile
What does Pallavi K. Lele inspect?
Pallavi K. Lele appears on 1 document on file covering 1 site, mostly in Tennessee.
What do they cite most often?
21 CFR 211.42(a) (design and construction features), followed by 21 CFR 211.192 and 21 CFR 211.100(b).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Pallavi K. Lele is dated Apr 27, 2018.